No, Rybelsus is a GLP-1 receptor agonist used to treat Type 2 diabetes
Importantly, these trials exhibited a high degree of heterogeneity in terms of the types of substances studied, patient characteristics, and treatment protocols, which posed significant challenges to drawing definitive conclusions
the USA
Medication-Related Factors and Personalization with Genetic Testing Your baseline medications, supplements, and genetic profile influence constipation risk on semaglutide
Monitoring requirements during the initial period include regular blood glucose checks if you have diabetes, particularly if you take insulin or sulfonylureas, as doses may need adjustment to prevent hypoglycaemia
This situation can have serious health implications